GE Capital Equity was the private equity investment arm of General Electric, focusing on maximizing returns through strategic equity investments. The firm specialized in acquiring minority ownership stakes in established companies with significant growth potential across various sectors, including healthcare, energy, transportation, and aviation. GE Capital Equity leveraged its extensive industry expertise and global reach to identify and support strong management teams in these high-growth areas. By engaging in investment opportunities such as growth capital, buy-out co-investments, and recapitalizations, the firm aimed to foster sustainable value creation and enhance the overall performance of its portfolio companies.
Cianna Medical, Inc. is a women’s health company focused on innovative solutions for the treatment of early-stage breast cancer. Based in Aliso Viejo, California, the company develops advanced medical technologies designed to enhance breast conservation therapy. Its primary products include SAVI SCOUT, a wire-free radar localization system that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation therapy to minimize damage to surrounding healthy tissue. Additionally, Cianna Medical provides BrachyBytes, an e-newsletter that shares insights and expert interviews on breast brachytherapy. Incorporated in 2007, the company aims to expand access to effective treatment options for women diagnosed with breast cancer, improving their chances for successful outcomes. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.
Cerapedics
Debt Financing in 2015
Cerapedics, Inc. is an orthobiologics company based in Westminster, Colorado, specializing in the development and commercialization of its proprietary small peptide technology platform, specifically the biomimetic peptide molecule known as P-15. The company focuses on creating innovative solutions for spinal applications and orthopedic procedures. Its primary offerings include i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural bone healing process, and i-FACTOR+ MATRIX for surgical implantation. Founded in 2000, Cerapedics aims to provide safer and more predictable bone formation options compared to traditional bone growth factors, thereby enhancing the effectiveness of spinal fusion surgeries and other orthopedic treatments.
Nobilis Health
Post in 2015
Nobilis Health is a healthcare development and management company based in Houston, Texas, that specializes in owning and managing ambulatory surgical centers (ASCs) and acute-care hospitals across the United States. The company operates through two main segments: Medical Services and Marketing. Its facilities offer a wide range of surgical procedures in various specialties, including orthopedic, gastro-intestinal, gynecological, and pain management, among others. Additionally, Nobilis Health provides marketing services, patient education, and care coordination to both its facilities and third-party healthcare providers. Founded in 2007, Nobilis has experienced significant changes, including a name change from Northstar Healthcare Inc. in 2014 and a voluntary petition for liquidation under Chapter 7 in 2019. As of December 2017, the company operated 32 locations, including hospitals, ASCs, and multi-specialty clinics.
USGI Medical
Venture Round in 2015
USGI Medical, Inc. is a medical technology company based in San Clemente, California, that focuses on developing innovative solutions for incisionless surgical procedures. The company offers specialized tools and an Incisionless Operating Platform (IOP) that allow surgeons and gastroenterologists to perform surgeries through a patient’s mouth or other natural orifices, eliminating the need for external abdominal incisions. This approach is designed to enhance patient recovery by reducing pain, shortening hospital stays, and minimizing the risk of wound infections while avoiding external scars. USGI Medical's technologies target various medical conditions, including obesity, gastroesophageal reflux disease, and natural orifice translumenal endoscopic surgery, aiming to meet the increasing demand from patients and healthcare providers for less invasive surgical options.
GenMark Diagnostics
Post in 2015
GenMark Diagnostics is a molecular diagnostics company specializing in the development and commercialization of innovative testing systems that utilize proprietary eSensor electrochemical detection technology. The company offers the ePlex instrument, which combines automated nucleic acid extraction and amplification, allowing for rapid testing of respiratory pathogens by placing patient samples directly into disposable test cartridges. Additionally, GenMark provides the XT-8 System, which has received FDA clearance and can analyze up to 24 test cartridges simultaneously, producing results within 30 minutes of receiving a sample. This system supports a variety of diagnostic tests, including those for respiratory viruses, cystic fibrosis, and hepatitis C genotyping. GenMark Diagnostics sells its products through direct sales and specialized service organizations in the United States and Europe, and is headquartered in Carlsbad, California. The company is also working on the next-generation AD-8 System, which aims to further streamline the testing process by integrating DNA amplification with its sensor detection technology.
Spiracur
Debt Financing in 2014
Spiracur Inc. is a privately held medical device company established in 2007 through the Stanford Biodesign Innovation Program. The company specializes in developing innovative wound healing technologies, focusing on the treatment needs of diabetic patients. Its flagship product, the SNaP Wound Care System, addresses the limitations of traditional negative pressure wound therapies by offering a portable and user-friendly solution. This system is designed to promote healing in chronic wounds, particularly those that are difficult to treat, allowing patients to recover more quickly and effectively. Spiracur is dedicated to creating patient-centric products that enhance the wound care experience for both patients and clinicians.
Schumacher Group
Debt Financing in 2014
Schumacher Group is one of the nation’s largest and fastest-growing health care resources, partnering with more than 3,000 providers to help treat more than 4 million patients annually. Our innovative, patient-centered solutions cover the entire continuum of care, including Emergency Medicine, Hospital Medicine, Care Management and Medical Billing.
CINQS
Debt Financing in 2014
CINQS is a smartphone application that links drivers with individuals seeking rides. Established in 2016 and headquartered in Nanterre, France, the company serves as a subsidiary of CHABÉ Limousines SAS, acquired by the Chabé Group, a prominent player in the European chauffeur-driven car market. CINQS aims to facilitate convenient transportation options for users while leveraging the expertise and resources of its parent company in the private hire sector.
Cardiva Medical
Debt Financing in 2014
Cardiva Medical, Inc. is a medical device company that specializes in vascular access management products designed to facilitate the body's healing process after catheterization procedures. The company offers several innovative products, including the VASCADE VCS, an extravascular and bioabsorbable femoral access closure system that promotes rapid hemostasis while reducing complications. Additionally, Cardiva Medical provides the Cardiva CATALYST, a manual compression assistance device that enhances coagulation for patients requiring temporary hemostasis. Another key product is the VASCADE MVP, which is used for multi-site venous closure during electrophysiology procedures, such as cardiac ablation. Founded in 2002 and headquartered in Santa Clara, California, Cardiva Medical serves physicians and cardiac centers throughout the United States, focusing on transforming vascular closure practices to improve patient outcomes.
InfoVista
Debt Financing in 2014
InfoVista is a developer of network performance and application control software, catering primarily to service providers, mobile operators, enterprises, and government organizations. The company offers a comprehensive product portfolio focused on managing 5G and next-generation networks through its Network Lifecycle Automation platform. This platform enables users to monitor and ensure the availability and quality of services across infrastructure, services, and applications. InfoVista's tools facilitate the planning, operation, optimization, and monetization of networks, providing clients with real-time insights that support critical business decision-making. By addressing unique cross-domain use cases, InfoVista empowers organizations to effectively manage their network performance and application control needs.
USGI Medical
Debt Financing in 2014
USGI Medical, Inc. is a medical technology company based in San Clemente, California, that focuses on developing innovative solutions for incisionless surgical procedures. The company offers specialized tools and an Incisionless Operating Platform (IOP) that allow surgeons and gastroenterologists to perform surgeries through a patient’s mouth or other natural orifices, eliminating the need for external abdominal incisions. This approach is designed to enhance patient recovery by reducing pain, shortening hospital stays, and minimizing the risk of wound infections while avoiding external scars. USGI Medical's technologies target various medical conditions, including obesity, gastroesophageal reflux disease, and natural orifice translumenal endoscopic surgery, aiming to meet the increasing demand from patients and healthcare providers for less invasive surgical options.
SINTX Technologies
Post in 2014
SINTX Technologies, Inc. is a biomaterial company specializing in the research, development, manufacturing, and commercialization of medical implant products made from silicon nitride. Founded in 1996 and headquartered in Salt Lake City, Utah, SINTX offers a range of ceramic-based biomaterial solutions applicable in various medical and industrial fields. The company primarily focuses on producing spinal implant products, marketed under the Valeo brand, which are used in cervical and thoracolumbar surgeries. SINTX operates an ISO 13485 certified manufacturing facility and collaborates with external partners, providing custom manufacturing and development of silicon nitride ceramics for both medical and non-medical applications. Its products are recognized for their biocompatibility, bioactivity, and excellent bone affinity, and have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.
Cianna Medical
Debt Financing in 2014
Cianna Medical, Inc. is a women’s health company focused on innovative solutions for the treatment of early-stage breast cancer. Based in Aliso Viejo, California, the company develops advanced medical technologies designed to enhance breast conservation therapy. Its primary products include SAVI SCOUT, a wire-free radar localization system that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation therapy to minimize damage to surrounding healthy tissue. Additionally, Cianna Medical provides BrachyBytes, an e-newsletter that shares insights and expert interviews on breast brachytherapy. Incorporated in 2007, the company aims to expand access to effective treatment options for women diagnosed with breast cancer, improving their chances for successful outcomes. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.
Del Taco
Debt Financing in 2014
Del Taco Restaurants Inc is a restaurant operator that specializes in fresh, made-to-order cuisine with a focus on both Mexican-inspired and American classic dishes. The company prepares all menu items using fresh ingredients, such as cheddar cheese grated from large blocks, handmade pico de gallo salsa, and slow-cooked, lard-free beans. Del Taco's diverse menu features offerings like tacos, burritos, quesadillas, nachos, hamburgers, crinkle-cut fries, and shakes, along with a full line of breakfast burritos. With approximately 564 locations, primarily in the Pacific Southwest, Del Taco operates as a franchisor, emphasizing quality and freshness in its food preparation.
Cerapedics
Debt Financing in 2014
Cerapedics, Inc. is an orthobiologics company based in Westminster, Colorado, specializing in the development and commercialization of its proprietary small peptide technology platform, specifically the biomimetic peptide molecule known as P-15. The company focuses on creating innovative solutions for spinal applications and orthopedic procedures. Its primary offerings include i-FACTOR, a peptide-enhanced bone graft designed to stimulate the natural bone healing process, and i-FACTOR+ MATRIX for surgical implantation. Founded in 2000, Cerapedics aims to provide safer and more predictable bone formation options compared to traditional bone growth factors, thereby enhancing the effectiveness of spinal fusion surgeries and other orthopedic treatments.
AirXpanders
Debt Financing in 2014
AirXpanders, Inc. was a medical device company founded in 2005 and headquartered in San Jose, California. It specialized in designing, manufacturing, and distributing devices aimed at improving breast reconstruction procedures. The company developed the AeroForm Tissue Expander System, a needle-free, patient-controlled device used for tissue expansion in patients undergoing two-stage breast reconstruction after mastectomy. AirXpanders operated in Australia, the United States, and Europe, focusing on enhancing the experience and outcomes for patients requiring breast reconstruction. However, on September 25, 2019, the company filed for Chapter 7 bankruptcy and ceased operations.
SynGen
Series C in 2014
SynGen Inc. specializes in the development, design, and manufacture of medical devices and laboratory systems aimed at cell separation, particularly focusing on the recovery of stem and progenitor cells while minimizing contamination. The company offers a range of products, including the SynGenX-1000 and SynGenX-2000 systems, which are closed sterile processing systems for isolating and preparing cells from umbilical cord blood and peripheral blood, respectively. Additionally, SynGen provides the CryoPRO-2 cryopreservation bag set, sterile docking workstations, and the SynGenX-Lab system for extracting target cell populations. Their offerings also include clinical software for data management and a semi-automated device for washing cell populations. SynGen's innovative approach combines engineering and life sciences to create solutions for regenerative medicine and is available in Europe and internationally. Founded in 2007 and headquartered in Sacramento, California, the company also has a location in Runcorn, United Kingdom, and operates as a subsidiary of ThermoGenesis Corp.
Tangent Medical Technologies
Debt Financing in 2014
Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath⢠Closed IV Catheter System, in 2012.
WKS Restaurant Group
Debt Financing in 2014
WKS Restaurant Corporation is a prominent franchisee in the United States, primarily operating multiple restaurant brands including El Pollo Loco, Wendy's, Denny's, Krispy Kreme Doughnuts, and Corner Bakery Cafe. Founded in 1987 and headquartered in Lakewood, California, the company has expanded its operations across California, Arizona, Denver, and El Paso. WKS Restaurant Corporation also emphasizes management training programs to ensure effective hiring and operational excellence within its franchise locations.
Chromatin
Series E in 2014
Chromatin is a biotech company developing and marketing innovative technologies and products that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Chromatin is unlocking the potential of plants to produce greater value and meaningful products for consumers, growers, seed producers, and bioprocessors. Chromatin is commercializing solutions that proactively address key societal challenges such as improving agricultural productivity and increasing renewable energy resources.
RadioShack
Venture Round in 2013
RadioShack is a retail company specializing in electronics goods, catering to consumers globally. It offers a diverse range of products including headphones, radios, batteries, and various electronic accessories, available both in its network of over 4,000 company-owned stores and through its online platform. The company distinguishes itself by fostering a collaborative shopping experience, where knowledgeable associates assist customers in bringing their technology ideas to life. This commitment to customer service is reflected in the positive feedback from shoppers who appreciate the expertise of the staff. RadioShack has also been revitalizing its stores, introducing a fresh, modern look and concept stores that serve as collaboration centers for tech enthusiasts. With a curated selection of products that includes personal and home technology, mobility solutions, and digital fitness items, RadioShack aims to meet the diverse needs of its customers while emphasizing the idea that collaboration leads to better solutions.
Drive Medical
Debt Financing in 2013
Drive Medical is one of the fastest growing global distributors of durable medical equipment. The Company markets and distributes its products to customers located throughout North America, Europe, Central America, South America, the Middle East and Asia. Drive has corporate offices and distribution facilities located throughout the United States, Canada, the United Kingdom, Germany, Romania, China and Taiwan. Drive North America Technical Service Center is located in Bohemia, New York. See the "Contact Us" section for all location details. Drive was formed in January 2000 under the name Medical Depot, Inc. Not long after the Company started, the ownership recognized the opportunity to reflect the spirit of the Company and the quality of life it provides to the users of their products, and therefore, changed the name to Drive. This culture and drive led to the significant growth and the formation of a multi-national organization. The continuous growth and expansion is supported by the best professionals in the business, state-of-the-art technology and an undying winning attitude.
Sonitus Medical
Debt Financing in 2013
Sonitus Medical Inc. is a privately held medical device company based in San Mateo, California, focused on delivering innovative hearing solutions for patients with hearing difficulties. The company is recognized as an emerging leader in bone conduction hearing devices, particularly through its flagship product, the SoundBite Hearing System. This system is notable for being the world's first non-invasive and removable hearing solution, which transmits sound through the teeth, leveraging the principle of bone conduction. The device is FDA cleared as a prosthetic option for treating single-sided deafness and conductive hearing loss. Sonitus Medical aims to expand its technology for future applications, including mixed hearing loss and tinnitus, along with potential consumer and covert communication uses. Founded in June 2006, the company collaborates with otologists, ENTs, and audiologists to enhance the auditory experience for patients.
Xand
Debt Financing in 2013
Xand is a premier facilities-based provider of data center managed services and technology solutions for clients requiring exceptional uptime, performance and support for mission-critical business operations. Since 1999, Xand has designed, built, and managed IT infrastructure services which allow enterprises to maximize their critical application performance and availability. Xand offers cost-efficient, custom designed solutions tailored to meet any organization’s requirements via colocation, cloud, enterprise hosting, managed services, business continuity/disaster recovery, and wide area networking platforms. These services and more are delivered across all of Xand’s best-in-class facilities, utilizing superior engineering expertise and unparalleled commitment to customer service to consistently deliver excellence.
Karro Food Group
Private Equity Round in 2013
Karro Food Group, headquartered in Malton, North Yorkshire, is a prominent producer of a wide range of pork products, including bacon, gammon, fresh pork, frozen sausage, ham, and cooked meats. The company processes approximately 45,000 pigs weekly, supplying high-quality meat to retail, food service, and manufacturing customers throughout the UK. With operations across various locations in England, Scotland, and Northern Ireland, Karro ensures full supply chain visibility for its products, which are available in major supermarkets and wholesale food suppliers. Employing around 3,000 individuals, Karro Food Group plays a significant role in the UK meat industry, providing pork consumed by millions of consumers annually.
Skylight Healthcare Systems
Debt Financing in 2013
Skylight is a technology company specializing in interactive patient care systems for hospitals. It offers the ACCESS interactive patient system, a comprehensive two-way digital communications platform that enhances the hospital experience by transforming television sets into interactive networks for information, education, and entertainment. This system allows patients to access vital information about their care, request assistance, view health education content, and provide real-time feedback through surveys. Additionally, Skylight provides iCarePassport, a web-based system that fosters ongoing patient engagement and personalized communication throughout the care continuum. Founded in 1999 and based in San Diego, California, Skylight aims to improve health literacy and the flow of critical information between patients and caregivers.
Plus Therapeutics
Post in 2013
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Austin, Texas, dedicated to the discovery, development, and manufacturing of innovative treatments for cancer and rare diseases. The company's lead product candidate, DocePLUS, is a protein-stabilized PEGylated liposomal formulation of docetaxel aimed at treating small cell lung cancer. Additionally, Plus Therapeutics is developing DoxoPLUS, a formulation of doxorubicin intended for breast and ovarian cancer, multiple myeloma, and Kaposi’s sarcoma. The company is also engaged in developing therapies for central nervous system cancers, including recurrent glioblastoma and leptomeningeal metastases, with a key candidate being rhenium (186Re) obisbemeda. Plus Therapeutics leverages proprietary nanotechnology to enhance drug delivery and efficacy while minimizing side effects. Founded in 1996, the company was previously known as Cytori Therapeutics, Inc. before rebranding in July 2019.
View
Series E in 2013
View is a technology company specializing in smart building solutions, particularly through its innovative smart windows. These windows utilize artificial intelligence to automatically adjust to sunlight, enhancing natural light access and providing unobstructed views while also minimizing heat and glare. This technology not only improves the health and overall experience of occupants but also reduces energy consumption and carbon emissions. View's products are integrated into a cloud-connected smart building platform, which includes essential infrastructure for power, networking, and communication. The company has successfully implemented its solutions in over 90 million square feet of various building types, including offices, hospitals, airports, educational institutions, hotels, and multifamily residences.
ASI System Integration
Debt Financing in 2013
ASI System Integration, Inc. is North America’s leading independent provider of IT services and solutions.
SINTX Technologies
Debt Financing in 2013
SINTX Technologies, Inc. is a biomaterial company specializing in the research, development, manufacturing, and commercialization of medical implant products made from silicon nitride. Founded in 1996 and headquartered in Salt Lake City, Utah, SINTX offers a range of ceramic-based biomaterial solutions applicable in various medical and industrial fields. The company primarily focuses on producing spinal implant products, marketed under the Valeo brand, which are used in cervical and thoracolumbar surgeries. SINTX operates an ISO 13485 certified manufacturing facility and collaborates with external partners, providing custom manufacturing and development of silicon nitride ceramics for both medical and non-medical applications. Its products are recognized for their biocompatibility, bioactivity, and excellent bone affinity, and have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.
Mayborn Group
Debt Financing in 2013
Mayborn Group is a manufacturer and retailer of baby and infant products based in Newcastle upon Tyne, United Kingdom. The company is best known for its feeding and bottle brand, Tommee Tippee, and provides a diverse range of essential items for children, including diaper bins, baby monitors, breast pumps, feeding bottles, and sterilizers. Mayborn Group focuses on delivering high-quality products that support the needs of parents and caregivers, ensuring access to vital baby supplies at reasonable prices. Additionally, the company offers soothing and hygiene products designed to enhance the well-being of infants.
CardioDx
Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.
Hospedia
Venture Round in 2012
Hospedia is a provider of point-of-care systems and clinical support software based in Pontefract, United Kingdom. The company specializes in delivering media, information, and infrastructure services to healthcare settings. With a dominant 75% market share in acute NHS hospitals across the UK, Hospedia has installed its bedside terminals in over 150 hospitals, effectively serving around 10 million patients, 5 million visitors, and 500,000 healthcare staff annually. Their platform enhances the patient experience by offering communication and multimedia services, ensuring that patients are both educated and entertained throughout their healthcare journey. This approach supports healthcare professionals in making timely and informed decisions by providing access to real-time information.
CardioDx
Private Equity Round in 2012
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.
C8 MediSensors
Series C in 2012
C8 MediSensors, Inc., a San Jose, CA-based developer of non-invasive continuous glucose monitors for diabetic patients.
Redapt
Venture Round in 2012
Redapt is a full-service systems integrator that specializes in delivering customized data center infrastructure and cloud solutions. The company caters to a diverse clientele, ranging from startups to Fortune 500 companies, with the aim of reducing costs and enhancing the value of their IT investments. Redapt offers a wide array of services, including artificial intelligence, machine learning, application modernization, and cloud adoption, allowing clients to select the services that best fit their needs. By providing these integrated solutions, Redapt enables organizations to focus their technical talent on core business objectives while optimizing their IT capabilities.
BG Medicine
Post in 2012
BG Medicine, Inc. is a life sciences company based in Waltham, Massachusetts, focused on the development and commercialization of diagnostic products aimed at guiding the treatment of patients with heart failure and related disorders. The company offers the BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 levels in serum or plasma, and the CardioSCORE Test, a multi-analyte blood test designed to assess the near-term risk of atherothrombotic cardiovascular events, such as heart attacks and strokes. BG Medicine has established partnerships with several prominent firms, including Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc., to develop automated versions of its tests and related assay kits. Founded in 2000, BG Medicine was previously known as Beyond Genomics, Inc. and rebranded in 2004.
MedShape
Debt Financing in 2012
MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.
Infraredx
Debt Financing in 2011
Infraredx, Inc. is a cardiovascular imaging medical device company focused on diagnosing and treating coronary artery diseases. Based in Burlington, Massachusetts, the company specializes in near-infrared spectroscopy (NIRS) technology, offering products such as the dual-modality NIRS-intravascular ultrasound (IVUS) True Vessel Characterization Imaging System, which identifies and characterizes lipid core coronary plaques. Other key products include the Makoto intravascular imaging system, the Dualpro catheter that combines IVUS and NIRS capabilities, and optical catheters that provide high-resolution images of plaque structures. Infraredx serves hospital sites primarily in the United States and Europe, and it operates as a subsidiary of Goodman USA, Inc. after being founded in 1998 and rebranding from InfraReDx, Inc. in 2012.
Solaredge Technologies
Venture Round in 2011
SolarEdge Technologies is a prominent player in the solar energy sector, specializing in direct current optimized inverter systems for various solar photovoltaic installations. Established in 2006, the company focuses on developing module-level electronics, including power optimizers and inverters, which enhance solar power harvesting and monitoring. SolarEdge's products are designed for a wide range of applications, catering to residential, commercial, and utility-scale markets. The company also offers a cloud-based monitoring platform, allowing users to optimize and track solar energy production effectively. SolarEdge sells its products directly to solar installers and engineering firms, as well as through distributors and electrical equipment wholesalers. With over 70% market share in the DC power optimizer segment, SolarEdge has made significant strides in promoting clean energy, having shipped millions of power optimizers to various countries and establishing a global presence across five continents.
Eurofactor
Acquisition in 2011
Eurofactor is a UK-based company specializing in credit services, including invoice discounting, invoice factoring, and asset-based lending. The firm also engages in debt collection by purchasing outstanding debts from businesses. In addition to these services, Eurofactor offers credit information and facilitates the collection of overseas payments, helping businesses manage their cash flow and reduce financial risk. Through its comprehensive range of services, Eurofactor aims to support companies in optimizing their financial operations and improving liquidity.
MCCI Medical Group
Private Equity Round in 2011
MCCI is a physician group that has expanded over the years from their origin as practicing physicians. They analyzed their ways of doing things and found ways to improve them. It has increased their attention to our patients, and has thereby improved our product and goal—their patients health. They have applied this model and have successfully grown to a group including over 100 Primary Care Physicians and 200 Affiliated Specialists.
Saladax Biomedical
Debt Financing in 2011
Saladax Biomedical, Inc. is a precision medicine company based in Bethlehem, Pennsylvania, specializing in the development and commercialization of diagnostic blood tests designed to enhance personalized medicine. The company focuses on adherence testing for psychiatrists and chemotherapeutic drug monitoring for oncologists. Its product line, known as MyCare, includes tests such as MyCare Psychiatry, which helps determine the appropriate antipsychotic dosage for patients; MyCare Oncology, which optimizes chemotherapy exposure; and MyCare Neurology, for assessing the effects of neurological drugs. Specific tests include My5-FU, MyPaclitaxel, MyDocetaxel, and MyImatinib, which are used to manage treatment for various cancers and conditions. Saladax markets its products through distributors across the Asia Pacific, European Union, Middle East, and North Africa, as well as through direct sales in select regions. With over 15 years of experience, Saladax aims to provide convenient and cost-effective solutions for therapeutic drug monitoring, enabling physicians to tailor drug dosing to individual patient needs.
Huaneng Renewables
Post in 2011
Huaneng Renewables Corporation Limited is a Chinese company focused on the development and operation of renewable energy projects, primarily in wind and solar energy. Established in November 2002, the company has constructed ten wind power plants and six wind power bases across various regions in China, including Northeast China and Sinkiang. Huaneng Renewables has been recognized for its quality engineering in the power sector and has pioneered several significant projects, such as the first domestic wind testing field and the first large-scale field using domestic equipment. The company invests in, constructs, acquires, and operates renewable energy facilities, generating most of its revenue from electricity sales produced at its wind and solar power plants. Huaneng Renewables is a wholly-owned subsidiary of Huaneng Group, a major state-owned electric utility company in China.
CardioDx
Private Equity Round in 2011
CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.
Datapipe
Debt Financing in 2011
Datapipe is a provider of managed hosting, cloud services, and data center solutions designed to manage and secure mission-critical IT services. The company offers a comprehensive range of services, including cloud computing, infrastructure as a service, platform as a service, colocation, business analytics, database management, e-commerce hosting, email hosting, and data protection. Datapipe serves a diverse array of industries, such as financial services, healthcare, manufacturing, government, and media, enabling clients to optimize both critical and everyday IT operations. With a presence in major global markets, including New York, Silicon Valley, London, Hong Kong, and Shanghai, Datapipe has established itself as a significant player in the technology landscape. The company was recognized in Gartner's Magic Quadrant for Cloud Infrastructure as a Service and Web Hosting in 2010, highlighting its commitment to delivering high-quality services.
NeoVista
Debt Financing in 2011
NeoVista Inc is focused on developing medical technologies aimed at improving the treatment of wet age-related macular degeneration (AMD), a condition that affects over 5 million people globally and is a leading cause of blindness among individuals over the age of 50. The company is engaged in clinical studies to validate its innovative technology, which shows promise in enhancing patient care and alleviating the challenges posed by this debilitating condition for both patients and healthcare providers. Through its efforts, NeoVista aims to significantly impact the quality of life for those affected by wet AMD.
eBioscience
Venture Round in 2011
eBioscience is a prominent provider of reagents essential for immunology and oncology research, specializing in flow cytometry. The company offers a vast array of antibodies, ELISAs, and proteins that support life science research and diagnostics. Recognized as an industry leader, eBioscience is particularly noted for its extensive selection of multicolor flow cytometry reagents, producing over 800 new products annually. Their innovative portfolio encompasses antibodies, fluorochromes, and other reagents tailored for applications in immunology, oncology, cell biology, stem cell biology, and diagnostics. As a privately held entity, eBioscience continues to play a critical role in advancing research capabilities within the pharmaceutical sector.
CareDx
Grant in 2011
CareDx, Inc. is a precision medicine company that specializes in developing and commercializing innovative healthcare solutions for transplant patients and their caregivers. The company offers a range of molecular diagnostics products, including AlloSure Kidney and AlloMap Heart, which utilize donor-derived cell-free DNA to assess organ transplant health and identify potential rejections noninvasively. CareDx also provides various solutions for human leukocyte antigen typing, chimerism testing, and post-transplant monitoring. Its offerings extend to patient tracking software and predictive analysis tools, enhancing the overall transplant experience from initial matching to ongoing care. Founded in 1998 and headquartered in South San Francisco, California, CareDx has established partnerships for the development and distribution of advanced genomic testing technologies, further solidifying its role as a leader in transplant diagnostics.
Loehmann's
Venture Round in 2009
Loehmann's, Inc. is an off-price retailer specializing in designer fashion apparel for both women and men, along with accessories and footwear. Founded in 1921 and headquartered in the Bronx, New York, the company offers a diverse range of products, including ladies' sportswear, dresses, career attire, and casual collections, as well as handbags, jewelry, and shoes for plus sizes, juniors, and children. Loehmann's features merchandise from well-known brands such as Calvin Klein, Diane Von Furstenberg, Kenneth Cole, Dolce & Gabbana, Valentino, Nicole Miller, Anne Klein, Donna Karan, and Michael Kors. The company operates multiple store locations across various states, including Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, New Jersey, New York, Pennsylvania, Texas, Virginia, and Washington. Loehmann's, Inc. is a subsidiary of Loehmann's Holdings, Inc.
TPI Composites
Series B in 2009
TPI Composites, Inc. is a manufacturer specializing in composite wind blades and related precision molding and assembly systems, primarily serving original equipment manufacturers in the wind energy and transportation sectors. Founded in 1968 and headquartered in Scottsdale, Arizona, the company has established a strong presence across various regions, including the United States, Mexico, Asia, Europe, the Middle East, Africa, and India. In addition to wind energy applications, TPI produces composite solutions for transportation, including structures for buses, rail systems, theme parks, and trucks. The company's manufacturing facilities enable efficient production and delivery of high-strength, lightweight, and durable composite structures tailored to meet the demanding needs of its diverse clientele.
Calypso Soft Drinks
Venture Round in 2009
They have been in the business for over 125 years, building a reputation in the UK for exceptional quality and customer satisfaction and we pride ourselves on the range that they offer. Most of their drinks are packed full of pure fruit juice like their Aquajuice range, so count as one of your five-a-day and they’re proud to say that a lot of their products are school approved. This means that children up and down the country can choose a healthy drink with their School dinner every day.
Micell Technologies
Series B in 2009
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.
SunGard
Debt Financing in 2009
SunGard Data Systems Inc. is a global provider of software and technology services, primarily serving the financial services, education, and public sectors. The company operates through four segments: Financial Systems, Higher Education, Public Sector, and Availability Services. The Financial Systems segment offers solutions that automate processes related to trading, investment portfolio management, and asset accounting, catering to financial institutions, corporate treasury departments, and energy companies. The Higher Education segment provides enterprise resource planning and administrative solutions for colleges and universities, addressing their academic and operational needs. The Public Sector segment focuses on software and services for K-12 education, government agencies, and public institutions, supporting various administrative functions and public safety initiatives. The Availability Services segment ensures uninterrupted access to critical IT systems through recovery and managed services. SunGard offers its solutions through traditional software and cloud-based models, emphasizing technology consulting and implementation services. Founded in 1983 and based in Wayne, Pennsylvania, SunGard Data Systems Inc. operates as a subsidiary of SunGard Holdco LLC.
SecureWorks
Series C in 2009
SecureWorks is a cybersecurity provider dedicated to delivering technology-driven solutions that protect organizations from evolving threats. The company specializes in information security, offering a range of services, including software-as-a-service (SaaS) solutions, managed security services, and professional services such as incident response and adversarial support. Its advanced offerings include Managed Detection and Response (MDR), Extended Detection and Response (XDR), Threat Hunting, Log Management, Next-Generation Antivirus (NGAV), Endpoint Detection and Response (EDR), and Intrusion Detection and Prevention Systems (IDPS). SecureWorks leverages a security information and event management (SIEM) platform, enhanced by applied security research and a team of fully certified experts, to help clients strengthen their cyber defenses, detect malicious activities in real-time, and effectively respond to security incidents. The company has been recognized in Gartner's Magic Quadrant for Managed Security Services Providers, underscoring its commitment to staying ahead of adversaries in the cybersecurity landscape.
Solaredge Technologies
Series B in 2009
SolarEdge Technologies is a prominent player in the solar energy sector, specializing in direct current optimized inverter systems for various solar photovoltaic installations. Established in 2006, the company focuses on developing module-level electronics, including power optimizers and inverters, which enhance solar power harvesting and monitoring. SolarEdge's products are designed for a wide range of applications, catering to residential, commercial, and utility-scale markets. The company also offers a cloud-based monitoring platform, allowing users to optimize and track solar energy production effectively. SolarEdge sells its products directly to solar installers and engineering firms, as well as through distributors and electrical equipment wholesalers. With over 70% market share in the DC power optimizer segment, SolarEdge has made significant strides in promoting clean energy, having shipped millions of power optimizers to various countries and establishing a global presence across five continents.
KSK Power Venture
Private Equity Round in 2008
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.
Grid Net
Series B in 2008
Grid Net is a software company that specializes in network management solutions for the utility sector, focusing on enhancing the capabilities of smart grid technologies. Its flagship product, the Machine-to-Machine Network Operating System, is designed to manage grid devices and advanced applications across various network types, whether public or private, wired or wireless. By providing open and interoperable communications products, Grid Net enables utilities to implement secure and scalable smart grid services, including smart metering. The company aims to support strategic deployments that deliver immediate returns and long-term value for its clients. Headquartered in San Francisco, California, with additional offices in Sydney, Melbourne, and Tokyo, Grid Net is supported by prominent investors, including Intel Capital and Cisco Systems.
Mzinga
Series D in 2008
Mzinga, Inc. specializes in providing enterprise social software solutions and services tailored for learning, marketing, and support sectors. The company offers a suite of products, including OmniSocial Learning, which fosters a collaborative social business ecosystem for enhanced learning and communication, and the OmniSocial Learning Extended Enterprise, aimed at customer acquisition and support. Mzinga also features the Learning Record Store, which facilitates tracking and reporting of user interactions, and Composica, a platform for collaborative e-learning content creation. Founded in 1986 and headquartered in Burlington, Massachusetts, Mzinga serves over 14,000 communities, facilitating approximately 2.5 billion monthly social interactions from 40 million unique visitors across 160 countries. The company's solutions are designed to improve business performance by enhancing brand visibility, workplace satisfaction, and customer loyalty.
Archus Orthopedics
Venture Round in 2008
Archus Orthopedics is focused on the development of implants to treat a variety of spine disorders that result from degenerative changes in the facet joints. Archus Orthopedics offers Total Facet Arthroplasty System, a spinal implant that is designed for patients suffering from lumbar spinal stenosis. Archus Orthopedics was acquired by Facet Solutions in November 2009. Archus Orthopedics was founded in 2001 and is based in Redmond, Washington.
InSightec
Venture Round in 2007
InSightec Ltd. specializes in developing and distributing the Exablate platform, which employs MR-guided focused ultrasound technology for non-invasive medical treatments in oncology and gynecology. The company offers solutions such as Exablate Neuro, designed for personalized thalamotomy to address movement disorders and pain without invasive surgery, and a thermal ablation technique for the treatment of uterine fibroids, which alleviates symptoms while minimizing damage to surrounding tissues. Founded in 1999 and headquartered in Tirat Carmel, Israel, InSightec has expanded its presence globally with operations in Europe, Asia, and the Americas. The Exablate system has received various regulatory approvals, including CE marks and FDA approval, and has been recognized with multiple innovation awards for its contributions to healthcare. In addition to its medical devices, InSightec provides clinical training, business support, maintenance, and customer services to healthcare facilities using its technology.
KSK Power Venture
Post in 2007
KSK Power Venture is a power project development company based in Hyderabad, India, specializing in the development, ownership, operation, and maintenance of power generation assets. Founded in 2001, the company operates primarily in two segments: project development and power generation. Its portfolio includes several operational power plants, such as the KSK Mahanadi Power plant in Chhattisgarh, which has a capacity of 3,600 megawatts, as well as various other coal, lignite, and natural gas-based plants across India. KSK Power Venture supplies electricity to industrial consumers and state-owned enterprises, focusing on capitalizing on growth opportunities within the Indian power sector. In addition to its core power generation activities, the company also explores natural and mineral resources and engages in investment and financing activities.
Vivid Restaurant Concepts
Venture Round in 2007
Vivid Restaurant Concepts is a company that operates a chain of restaurants across the United States. It focuses on providing a diverse range of cuisines to cater to the tastes and preferences of its customers. Through its various dining establishments, Vivid Restaurant Concepts aims to deliver quality food and an enjoyable dining experience, appealing to a broad audience.
Micell Technologies
Series A in 2007
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.
A123 Systems
Series C in 2007
A123 Systems is a manufacturer of rechargeable lithium-ion batteries and battery systems, specializing in efficient power supply solutions for electronic devices. The company leverages advanced nanoscale materials, particularly its proprietary Nanophosphate electrode technology, which offers significant advantages in performance and cost. A123's cell and electrode designs result in lower costs per watt and watt-hour, while providing higher voltage compared to traditional long-life systems. This technology also contributes to a longer battery life, reducing overall lifecycle and system costs, thereby enhancing price-performance for clients. A123 Systems competes with other industry players such as Valence, Saft, and Lion Cells.
Brightcove
Series B in 2006
Brightcove is a video technology company that has been in operation since 2004, providing cloud-based streaming solutions to a diverse range of clients, including media companies, broadcasters, digital publishers, and various sectors such as sports, entertainment, retail, and education. The company's flagship product, Brightcove Video Cloud, enables organizations to publish and distribute video content across Internet-connected devices, facilitating professional video experiences. Brightcove's offerings are designed to empower businesses to engage their audiences in innovative ways, leveraging advanced technologies and a robust global infrastructure. With a focus on customer support and service excellence, Brightcove aims to harness the compelling nature of video to drive business success.
LipoScience
Series F in 2006
LipoScience, based in Raleigh, North Carolina, specializes in developing in vitro diagnostic tests utilizing nuclear magnetic resonance (NMR) technology. The company's flagship product, the NMR LipoProfile test, quantifies low density lipoprotein particles (LDL-P) in blood samples, offering crucial insights for physicians and patients to tailor heart disease risk management. With more than 8 million tests ordered, LipoScience is at the forefront of personalized diagnostics, providing actionable data that enhances patient care and treatment strategies.
Carmen Systems
Venture Round in 2006
Carmen Systems develops, markets and implements resource optimization solutions for clients found primarily in the transportation industry. Carmen Systems’ software solutions improve our clients’ productivity and bottom-line profitability. Our solutions combine the latest in research and technology and include analysis, simulation, development and implementation. Of approximately 290 employees from 32 nationalities, around one third work with R&D, of these 12 per cent have a PhD. Collaboration with a number of leading universities in different countries further contributes to Carmen Systems’ strength in the field of resource optimization. The company headquarters is in Göteborg, Sweden with offices in Amsterdam, Austin (Texas), Brisbane (Australia), Copenhagen, London, Madrid, Monterrey (Mexico), Montreal, Paris, Singapore and Stockholm. Carmen Systems is owned by its management and employees, GE Commercial Finance, Gilde IT Fund B.V., and InnovationsKapital.
Singulex
Series C in 2006
Singulex, Inc. is an immunodiagnostics and biotechnology company that specializes in single molecule counting (SMC) technology for clinical diagnostics and scientific research. The company has developed the Sgx Clarity System, an in vitro diagnostics platform capable of detecting low abundance biomarkers at levels down to femtograms/mL. This system assists clinicians in managing cardiovascular health, while also providing heart disease monitoring services and personalized wellness programs for patients. Singulex's offerings include ultra-sensitive immunoassay solutions and laboratory testing services that facilitate both reactive and proactive health management, as well as support the discovery of new therapeutics. The company serves a diverse clientele, including pharmaceutical research laboratories, clinical research organizations, and academic institutions globally. Additionally, Singulex is involved in pilot studies to validate its Erenna BioAssay System, which enhances molecular detection capabilities. Founded in 1997 and based in Alameda, California, Singulex has an additional office in Basel, Switzerland, and was previously known as BioProfile Corporation until its name change in 2003.
A123 Systems
Series B in 2006
A123 Systems is a manufacturer of rechargeable lithium-ion batteries and battery systems, specializing in efficient power supply solutions for electronic devices. The company leverages advanced nanoscale materials, particularly its proprietary Nanophosphate electrode technology, which offers significant advantages in performance and cost. A123's cell and electrode designs result in lower costs per watt and watt-hour, while providing higher voltage compared to traditional long-life systems. This technology also contributes to a longer battery life, reducing overall lifecycle and system costs, thereby enhancing price-performance for clients. A123 Systems competes with other industry players such as Valence, Saft, and Lion Cells.
RPO
Series B in 2006
RPO, Inc. develops, designs, and manufactures waveguides for the consumer electronics market. The company’s products include digital waveguide touch systems, which is a touch screen solution applied in various products, including gameplayers, cellphones, PDAs, GPS systems, automotive control displays, multimedia players, and tablet personal computers, as well as in ATM’s and gambling machines. It also manufactures polymer optical waveguides on wafer and panel substrates. The company was incorporated in 2005 and is headquartered in San Jose, California. It has a research and development facility in Canberra, Australia; and pilot assembly operations in Sydney, Australia.
Univa
Venture Round in 2005
Univa Corporation, founded in 2004 and based in Hoffman Estates, Illinois, specializes in enterprise-class workload management and containerization solutions. The company offers a range of products, including Univa Grid Engine, a distributed resource management system designed to optimize data center resources. Its offerings also feature various add-ons such as Container Edition, which enhances the efficiency of Docker containers; Short Jobs, which enables rapid task execution; and License Orchestrator for managing licensed application features across clusters. Additionally, Univa provides the Universal Resource Broker for hosting big data frameworks, UniSight Reporting for usage analytics, UniCloud for leveraging cloud resources, and Navops, a cloud-automation platform. These solutions empower organizations to manage and optimize applications, containers, and data center services effectively. Univa operates additional offices in Markham, Canada, and Munich and Regensburg, Germany, and it is a subsidiary of Altair Engineering Inc.
Redfern Integrated Optics
Series C in 2005
Redfern Integrated Optics develops and manufactures optical transmitters based on proprietary PLANEX (Planar External Cavity Laser) technology, which enables high performance at low cost for various applications. RIO planar ECL consists of a gain chip and a planar waveguide circuit (PLC) with Bragg grating which forms a laser cavity. This has significant advantages such as; very narrow spectral linewidth, low phase noise and RIN, optimized chirp, low wavelength sensitivity to temperature and bias current, and low power consumption.
OutlookSoft
Series D in 2005
OutlookSoft is a provider of business planning and performance management solutions, established in 1999 and headquartered in Stamford, Connecticut. The company specializes in predictive performance management, offering a comprehensive platform that includes tools for strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to enhance client experience and effectiveness. Its offerings cater to a diverse range of industries, including manufacturing, financial services, and the public sector, enabling organizations to effectively measure, manage, and predict their financial and operational performance. The company has expanded its reach with additional offices in the United States, the United Kingdom, France, Switzerland, and Italy.
Speed Commerce
Post in 2005
Speed Commerce, Inc. is a provider of comprehensive e-commerce and fulfillment services for retailers and manufacturers across the United States and Canada. Established in 1983 and headquartered in Richardson, Texas, the company offers a range of services including web platform development, order management, fulfillment, logistics, and contact center support. These services are designed to deliver transaction-based solutions and information management tools tailored to client needs. Speed Commerce operates fulfillment centers in Pennsylvania, Ohio, Missouri, and Texas, employing advanced automation technologies such as unit sortation and RF scanning to enhance efficiency. The company, which rebranded from Navarre Corporation in 2013, focuses on delivering flexible solutions and high-quality services to help its clients grow their businesses.
Iridian Technologies
Series C in 2005
Iridian Technologies, Inc. specializes in the research, development, and marketing of biometric identification solutions, focusing primarily on iris recognition technology. The company offers PrivateID, an image processing protocol that enables certified iris cameras to capture and process images for secure transport. Additionally, it provides the KnoWho authentication server and related developer tools, along with hardware and software certification programs. Iridian's products are designed to enhance security in various public applications, including passenger travel, border control, national identification, and election verification. The company distributes its authentication server software through integrators and application partners, catering to sectors that require reliable identity verification. Founded in 1990 and based in Moorestown, New Jersey, Iridian Technologies was previously known as IriScan, Inc. before rebranding in 2000.
CiCi's Pizza
Venture Round in 2005
CiCi's Pizza began in 1985 with a single restaurant in Plano, Texas, and has since expanded to over 450 locations across 32 states. The company is known for pioneering the unlimited pizza buffet concept, allowing customers to enjoy a diverse selection of pizzas, including traditional crust and flatbreads, as well as pasta, salads, and desserts. This business model caters to a variety of tastes, enabling guests to explore and enjoy different flavors of Italian cuisine in a casual dining setting. CiCi's Pizza emphasizes customer satisfaction by encouraging patrons to personalize their dining experience.
WIS International
Corporate Round in 2004
WIS International Ltd. is a provider of inventory and data collection services, catering to retailers and various sectors worldwide, including healthcare, manufacturing, and logistics. Founded in 1967 and based in Mississauga, Canada, with additional locations in San Diego, California, and Flower Mound, Texas, the company offers a range of services such as physical inventory counting, inventory consulting, information management, and merchandising. WIS International specializes in optimizing inventory processes, enhancing accuracy, and reducing costs for its clients through innovative technology solutions. The company was previously known as Western Inventory Service Ltd. before rebranding in April 2005.
AGY Therapeutics
Series C in 2004
AGY Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for central nervous system (CNS) diseases. The company targets neurodegenerative diseases, CNS injuries, stroke, cognitive disorders, and schizophrenia, with a diverse pipeline that includes both clinical and preclinical programs. AGY has developed a proprietary platform for functional gene discovery, which aids in identifying and validating therapeutic targets that can modulate disease progression. Key programs in their pipeline include treatments for stroke, cognitive impairment, and schizophrenia, as well as various antibody and receptor therapies. Founded in 1998 and based in South San Francisco, California, AGY Therapeutics aims to address significant unmet medical needs in the CNS therapeutic landscape.
OutlookSoft
Series D in 2004
OutlookSoft is a provider of business planning and performance management solutions, established in 1999 and headquartered in Stamford, Connecticut. The company specializes in predictive performance management, offering a comprehensive platform that includes tools for strategic planning, budgeting, forecasting, statutory consolidation, reporting, analysis, predictive analytics, scorecarding, and dashboards. In addition to its software solutions, OutlookSoft provides consulting, training, implementation, and ongoing support services to enhance client experience and effectiveness. Its offerings cater to a diverse range of industries, including manufacturing, financial services, and the public sector, enabling organizations to effectively measure, manage, and predict their financial and operational performance. The company has expanded its reach with additional offices in the United States, the United Kingdom, France, Switzerland, and Italy.
Atlantic Broadband
Debt Financing in 2004
Atlantic Broadband, founded in 2003 and based in Quincy, Massachusetts, operates cable systems across several states including Pennsylvania, Florida, Maryland, West Virginia, Delaware, South Carolina, and New York. The company provides a range of services such as cable television video and programming, Wi-Fi for homes and small businesses, high-speed data services, home networking equipment, and support services. Additionally, Atlantic Broadband offers cable telephony services for residential subscribers, hosted voice services for businesses, and various advanced broadband services. The company also sells local advertising on satellite-delivered channels and provides equipment rental, installation, and reconnection services. Atlantic Broadband delivers its products through direct sales, telemarketing, web-based, and retail channels.
LipoScience
Series E in 2003
LipoScience, based in Raleigh, North Carolina, specializes in developing in vitro diagnostic tests utilizing nuclear magnetic resonance (NMR) technology. The company's flagship product, the NMR LipoProfile test, quantifies low density lipoprotein particles (LDL-P) in blood samples, offering crucial insights for physicians and patients to tailor heart disease risk management. With more than 8 million tests ordered, LipoScience is at the forefront of personalized diagnostics, providing actionable data that enhances patient care and treatment strategies.
Fiberlink
Series C in 2003
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
Innovative Spinal Technologies
Series A in 2003
Innovative Spinal Technologies is a spine technology company based in Mansfield, Massachusetts, that specializes in developing motion preservation and minimally invasive treatments for spinal disorders. Founded in 2002, the company offers a range of products designed to enhance surgical outcomes in spinal procedures. Its AXIENT Dynamic Fixation system is a pedicle screw-based motion system, while the PARAMOUNT product line includes several systems tailored for lumbar fusion procedures. This includes the PARAMOUNT Lumbar Fusion System, which can be used in minimally invasive, mini-open, or open surgical techniques, as well as the PARAMOUNT MIS and Open Pedicle Screw Systems, designed for single and multi-level procedures. Additionally, the PARAMOUNT VBR is engineered for a minimally invasive transforaminal approach.
Zilliant
Series B in 2002
Zilliant provides price optimization and management software tailored for manufacturing, distribution, high-tech, and industrial service companies. Their solutions enable businesses to analyze pricing strategies, optimize prices, manage price lists, and handle quoting and negotiation processes. Key offerings include the Zilliant Precision Pricing Suite (ZPPS), which integrates price segmentation, optimization science, analytics, and process automation. Additionally, Zilliant offers tools for deal management, price campaign management, and pricing information management. The company also provides deployment strategies, implementation methodologies, and educational services to support business and technical users. Founded in 1999, Zilliant is headquartered in Austin, Texas.
BEELINE Technologies
Venture Round in 2002
BEELINE Technologies is the global software partner for clients requiring integrated autonomous control and navigation technologies for land-based vehicles. Quality assured and agile, we develop integrated solutions across all industries. For more than 10 years, the company’s diverse and experienced teams have worked with original equipment manufacturers and technology organisations, to deliver flexible, leading-edge technology solutions for self-propelled, ground-based vehicles. BEELINE is proud of its pioneering spirit, and its innovative, autonomous solutions are used extensively around the world. BEELINE’s commitment to product innovation continues through its investment in sophisticated technology research and development programs that deliver outstanding solutions to our clients. BEELINE is in an exciting growth phase that continues to build value for its existing clients, whilst applying that experience, knowledge, and capability to new industries and technologies.
Confluent Surgical
Series C in 2002
Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.
AnnuityNet
Series B in 2002
AnnuityNet is a supplier of on-demand software and e-commerce services to the insurance, financial, and healthcare industries.
IP Communications
Series C in 2002
Dallas-based IP Communications (IPC) has the most extensive broadband network in Texas, Missouri, Oklahoma and Kansas. IP Communications provides wide-area networking services to replace traditional private line, frame relay and ISDN with cost effective packet-based solutions. Our next-generation packet-switched network uses a redundant ATM backbone and advanced switching capabilities to provide high quality bundled communication services to all of our customers.
IntraLuminal Therapeutics
Venture Round in 2002
IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The company’s platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and men’s and women’s health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.
SoftSwitching Technologies
Series C in 2002
SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a range of products, including battery-free DySC systems, intelligent I-Sense sensors that detect the timing and duration of voltage sags, and Grid Alert event notifications, which are part of a global power reporting network. Their offerings are designed to identify and mitigate brief power disruptions, thereby enhancing operational uptime and efficiency in manufacturing processes. Overall, SoftSwitching Technologies aims to deliver effective and scalable solutions that address the critical power quality needs of various sectors.
LaserComm
Series D in 2002
Lasercomm Inc was founded in 1998. The company's line of business includes providing telephone voice and data communications services. LaserComm is a privately held Israeli company. The company has developed a technology which established the foundation of a new breed of photonic components and modules for fiber optic networks. Based on its core competence, LaserComm aims to break new grounds in the field of dispersion management. The company develops products specifically designed to increase bandwidth, improve reliability, and reduce the cost of services provided by long-haul and ultra long-haul carriers.
Achillion Pharmaceuticals
Venture Round in 2002
Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company based in Blue Bell, Pennsylvania, focused on discovering and developing small molecule drug therapies for immune system disorders. The company's lead candidate, ACH-4471, is a factor D inhibitor currently undergoing Phase II clinical trials for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and C3 glomerulopathy. Additionally, Achillion is developing two other factor D inhibitors, ACH-5228 and ACH-5548, both in Phase I clinical trials for PNH and other complement-mediated diseases. The company also has licensing agreements with Ora, Inc. for the development of ACH-702, and with GCA Therapeutics, Ltd. for elvucitabine, a treatment for hepatitis B and HIV. Founded in 1998, Achillion aims to advance its portfolio of therapies targeting the complement system, which plays a crucial role in various immune-related conditions.
Mesa Communications Group
Venture Round in 2002
Mesa Communications Group is a network of clustered community towers designed to accommodate wireless communication operators. It provides tower space to the wireless communications industry. The company develops a network of clustered community towers designed to accommodate wireless communication operators, including broadband wireless carriers, and FM and TV broadcasters, as well as paging, government, and other private land mobile radio operators. Mesa Communications Group was founded in 1999 and is based in Falls Church, Virginia.
Catalytic Solutions
Series C in 2002
Catalytic Solutions manufactures and distributes emissions control systems and catalytic products for commercial and industrial applications. It manufactures nanostructured catalysts at its main facility in Oxnard, California. The company’s products are most commonly applied to automobile, diesel engine, and energy markets. Catalytic Solutions has manufacturing facilities in Oxnard, California; Reno, Nevada; Thornhill, Canada; and Malmo, Sweden. Catalytic Solutions, Inc. operates as a subsidiary of Clean Diesel Technologies Inc.
DotCast
Series C in 2002
Dotcast, Inc. is a privately held company focused on developing a high-speed wireless broadband network that aims to deliver substantial amounts of rich media and digital content to consumers and businesses across the United States. The company specializes in broadband communications technology and digital data distribution, enabling cable operators to provide comprehensive digital services utilizing their current infrastructure. Dotcast's solutions include antenna products for receiving both digital and analog broadcast signals and terrestrial datacasting technologies that allow broadcasters and content providers to transmit high-capacity data streams over existing television infrastructure. This innovative approach offers various industries a cost-effective distribution channel for reaching their audiences directly.
R2 Technology
Venture Round in 2001
R2 Technology develops and commercializes computer-aided detection systems for the early-detection of breast cancer. R2 Technology pioneered the use of CAD for mammography in 1998 when the ImageChecker system became the first CAD system approved by the FDA for screening mammography. The company was founded in 1993 and is headquartered in Santa Clara, California. As of July 13, 2006, R2 Technology, Inc. operates as a subsidiary of Hologic Inc.
Intraspect Software
Venture Round in 2001
Intraspect Software specializes in inter-enterprise solutions that enhance collaborative business processes. Founded in 1995 and acquired by Vignette in 2003, the company offers portal collaboration tools that allow users to create shared communities focused on strategic accounts, products, and business processes. Its flagship product, Intraspect 5.5, features architectural improvements suited for inter-enterprise deployments, while C-mail Services facilitate user interaction with Intraspect solutions through effective communication channels. The company’s software is particularly beneficial for industries such as financial services and high technology, enabling cross-functional teams to collaborate and communicate effectively with customers, suppliers, and partners across various organizational and geographic boundaries.
Standard BioTools
Series C in 2001
Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.
Citadon
Venture Round in 2001
Citadon is a provider of internet-based project collaboration and business process management services, primarily serving the engineering and construction sector. The company offers a diverse range of solutions, including CAFM explorer, collaboration workspace, docleader, McLaren enterprise, fusion, and OPIDIS. Its services cater to various clients in industries such as construction, oil and gas, life sciences, energy, and nuclear sectors. Founded by Tawfik Hammound, Citadon is headquartered in California and focuses on meeting the needs of architects, engineers, contractors, and facility managers through its innovative project collaboration tools.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.